183437-80-1Relevant articles and documents
Identification of a novel conformationally constrained glucagon receptor antagonist
Lee, Esther C.Y.,Tu, Meihua,Stevens, Benjamin D.,Bian, Jianwei,Aspnes, Gary,Perreault, Christian,Sammons, Matthew F.,Wright, Stephen W.,Litchfield, John,Kalgutkar, Amit S.,Sharma, Raman,Didiuk, Mary T.,Ebner, David C.,Filipski, Kevin J.,Brown, Janice,Atkinson, Karen,Pfefferkorn, Jeffrey A.,Guzman-Perez, Angel
, p. 839 - 844 (2014/02/14)
Identification of orally active, small molecule antagonists of the glucagon receptor represents a novel treatment paradigm for the management of type 2 diabetes mellitus. The present work discloses novel glucagon receptor antagonists, identified via confo
Synthesis and characterization of cyclometalated iridium(III) complexes containing pyrimidine-based ligands
Lin, Cing-Fong,Huang, Wei-Sheng,Chou, Hsien-Hsin,Lin, Jiann T.
experimental part, p. 2757 - 2769 (2009/12/06)
New pyrimidine derivatives (pyr) have been synthesized using palladium-catalyzed Suzuki coupling reaction. These compounds can undergo cyclometalation with iridium trichloride to form bis-cyclometalated iridium complexes, (pyr)2Ir(acac) (acac =
Pyrimidine compounds
-
, (2008/06/13)
5-Bromo-2-iodopyrimidine is used to synthesize a range of chemical compounds including liquid crystalline compounds.
